Clinical outcomes after endovascular treatment of superficial femoral disease in patients with disabling claudication and critical limb ischemia

Midterm analysis

A. J. Misselt, M. D. Zielinski, O. I Garcia Medina, Gustavo Oderich, H. Bjarnason, M. A. McKusick, Sanjay Misra

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We present the midterm clinical outcomes and predictors of balloon angioplasty and stent placement in atherosclerotic femoropopliteal (FP) arterial disease. Between January 2002 and August 2006, 155 patients (men = 56%; 71.4 ± 10.5 years) underwent 171 FP angioplasty or stent for claudication (n = 82, 54%) or critical limb ischemia ([CLI] n = 70, 46%). Follow-up was obtained through September 30, 2009. The average follow-up was 3.25 ± 1.73 years. In claudicants versus CLI, the 12-month patency for TransAtlantic InterSociety Consensus II (TASC II) classification (TASC A/B) was 93% versus 80%, respectively, and TASC C/D 83% versus 80%. At 3 years, TASC A/B was 82% versus 80%, respectively, and TASC C/D was 56% versus 80%, respectively. The predictor of clinical failure in claudicants was chronic renal insufficiency (CRI) and in CLI, the predictor of amputation was hyperlipidemia.

Original languageEnglish (US)
Pages (from-to)259-265
Number of pages7
JournalAngiology
Volume63
Issue number4
DOIs
StatePublished - May 2012

Fingerprint

Thigh
Ischemia
Extremities
Stents
Balloon Angioplasty
Hyperlipidemias
Chronic Renal Insufficiency
Amputation
Angioplasty
Therapeutics

Keywords

  • angioplasty
  • outcomes
  • stent
  • superficial femoral arterial disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Clinical outcomes after endovascular treatment of superficial femoral disease in patients with disabling claudication and critical limb ischemia : Midterm analysis. / Misselt, A. J.; Zielinski, M. D.; Medina, O. I Garcia; Oderich, Gustavo; Bjarnason, H.; McKusick, M. A.; Misra, Sanjay.

In: Angiology, Vol. 63, No. 4, 05.2012, p. 259-265.

Research output: Contribution to journalArticle

@article{54f2f80a99334fe59b64f540b731fdb6,
title = "Clinical outcomes after endovascular treatment of superficial femoral disease in patients with disabling claudication and critical limb ischemia: Midterm analysis",
abstract = "We present the midterm clinical outcomes and predictors of balloon angioplasty and stent placement in atherosclerotic femoropopliteal (FP) arterial disease. Between January 2002 and August 2006, 155 patients (men = 56{\%}; 71.4 ± 10.5 years) underwent 171 FP angioplasty or stent for claudication (n = 82, 54{\%}) or critical limb ischemia ([CLI] n = 70, 46{\%}). Follow-up was obtained through September 30, 2009. The average follow-up was 3.25 ± 1.73 years. In claudicants versus CLI, the 12-month patency for TransAtlantic InterSociety Consensus II (TASC II) classification (TASC A/B) was 93{\%} versus 80{\%}, respectively, and TASC C/D 83{\%} versus 80{\%}. At 3 years, TASC A/B was 82{\%} versus 80{\%}, respectively, and TASC C/D was 56{\%} versus 80{\%}, respectively. The predictor of clinical failure in claudicants was chronic renal insufficiency (CRI) and in CLI, the predictor of amputation was hyperlipidemia.",
keywords = "angioplasty, outcomes, stent, superficial femoral arterial disease",
author = "Misselt, {A. J.} and Zielinski, {M. D.} and Medina, {O. I Garcia} and Gustavo Oderich and H. Bjarnason and McKusick, {M. A.} and Sanjay Misra",
year = "2012",
month = "5",
doi = "10.1177/0003319711414866",
language = "English (US)",
volume = "63",
pages = "259--265",
journal = "Angiology",
issn = "0003-3197",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Clinical outcomes after endovascular treatment of superficial femoral disease in patients with disabling claudication and critical limb ischemia

T2 - Midterm analysis

AU - Misselt, A. J.

AU - Zielinski, M. D.

AU - Medina, O. I Garcia

AU - Oderich, Gustavo

AU - Bjarnason, H.

AU - McKusick, M. A.

AU - Misra, Sanjay

PY - 2012/5

Y1 - 2012/5

N2 - We present the midterm clinical outcomes and predictors of balloon angioplasty and stent placement in atherosclerotic femoropopliteal (FP) arterial disease. Between January 2002 and August 2006, 155 patients (men = 56%; 71.4 ± 10.5 years) underwent 171 FP angioplasty or stent for claudication (n = 82, 54%) or critical limb ischemia ([CLI] n = 70, 46%). Follow-up was obtained through September 30, 2009. The average follow-up was 3.25 ± 1.73 years. In claudicants versus CLI, the 12-month patency for TransAtlantic InterSociety Consensus II (TASC II) classification (TASC A/B) was 93% versus 80%, respectively, and TASC C/D 83% versus 80%. At 3 years, TASC A/B was 82% versus 80%, respectively, and TASC C/D was 56% versus 80%, respectively. The predictor of clinical failure in claudicants was chronic renal insufficiency (CRI) and in CLI, the predictor of amputation was hyperlipidemia.

AB - We present the midterm clinical outcomes and predictors of balloon angioplasty and stent placement in atherosclerotic femoropopliteal (FP) arterial disease. Between January 2002 and August 2006, 155 patients (men = 56%; 71.4 ± 10.5 years) underwent 171 FP angioplasty or stent for claudication (n = 82, 54%) or critical limb ischemia ([CLI] n = 70, 46%). Follow-up was obtained through September 30, 2009. The average follow-up was 3.25 ± 1.73 years. In claudicants versus CLI, the 12-month patency for TransAtlantic InterSociety Consensus II (TASC II) classification (TASC A/B) was 93% versus 80%, respectively, and TASC C/D 83% versus 80%. At 3 years, TASC A/B was 82% versus 80%, respectively, and TASC C/D was 56% versus 80%, respectively. The predictor of clinical failure in claudicants was chronic renal insufficiency (CRI) and in CLI, the predictor of amputation was hyperlipidemia.

KW - angioplasty

KW - outcomes

KW - stent

KW - superficial femoral arterial disease

UR - http://www.scopus.com/inward/record.url?scp=84859751578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859751578&partnerID=8YFLogxK

U2 - 10.1177/0003319711414866

DO - 10.1177/0003319711414866

M3 - Article

VL - 63

SP - 259

EP - 265

JO - Angiology

JF - Angiology

SN - 0003-3197

IS - 4

ER -